As a premier international law firm, Ropes & Gray routinely represents clients in high-profile matters. In addition, our attorneys are regularly cited in top daily and trade publications for comment and analysis on important issues. 

In S&P Global Market Intelligence, Joshua Lichtenstein Discusses Tailored ESG Messaging for Investment Advisors

In The News ESG, CSR and Business and Human Rights, Corporate & Securities Litigation, ERISA, Asset Management, Securities & Public Companies, Investment Management, Employment, Executive Compensation & Employee Benefits

In an S&P Global Market Intelligence article, Joshua Lichtenstein, employment, executive compensation and employee benefits partner and head of the firm's ERISA ...

In Bloomberg Law, Margaux Hall Discusses Drugmaker Data Protection in Medicare Price Negotiation Guidance

In The News Health Care, Drug Pricing & Price Reporting, Managed Care, Health Care Finance & Restructuring, Health Information Technology & Electronic Health Records, Health Privacy & Security, Regulatory Enforcement & Civil Litigation

In a Bloomberg Law article, health care partner Margaux Hall discussed drug manufacturer data protection issues in the newly released Medicare drug price negotiation guidance ...

Ropes & Gray Advises Provention Bio in $2.9 Billion Sale to Sanofi

In The News Mergers & Acquisitions, Capital Markets, Securities & Public Companies, Corporate Governance & Compliance, Intellectual Property, Antitrust, Executive Compensation & Employee Benefits, Litigation, Tax, Business Restructuring, Data, Privacy & Cybersecurity

Ropes & Gray represented Provention Bio, Inc., a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, in a sales agreement to global healthcare ...

Cookie Settings